Src family nonreceptor protein tyrosine kinases transduce signals that control normal cellular processes such as cell proliferation, adhesion and motility. Normally, cellular Src is held in an inactive state, but in several cancer types, abnormal events lead to elevated kinase activity of the protein and cause pleiotropic cellular responses inducing transformation and metastasis. A prerequisite of the ability of a cancer cell to undergo metastasis into distant tissues is to penetrate surrounding extracellular matrices. These processes are facilitated by the integrin family of cell adhesion molecules. As is the case with Src, altered integrin activity or substrate affinity can contribute to the neoplastic phenotype. Therefore, understanding the interplay between Src and integrin function has been of intense interest over the past few years. This review focuses on the role of Src and integrin signaling in normal cells and how this is deregulated in human cancer. We will identify the key players in the integrin-mediated signaling pathways involved in cell motility and apoptosis, such as FAK, paxillin and p130 CAS , and discuss how Src signaling affects the formation of focal adhesions and the extracellular matrix.
Introduction
Src is a nonreceptor tyrosine kinase of molecular weight 60 kDa. Widespread interest in Src initially arose from the seminal discovery that the transforming element of the Rous sarcoma virus (v-Src) in chickens was a transduced form of the cellular gene (herein termed Src). Src is the founding member of a family of proteins (Src family kinases or SFKs) comprising nine family members, Src, Fyn, Yes, Lck, Hck, Blk, Fgr, Lyn and Yrk (Thomas and Brugge, 1997) . Each possesses an amino-terminal domain, which may undergo myristoylation, an SH3 and SH2 domain, a tyrosine kinase domain and a carboxy-terminal negative regulatory element (Thomas and Brugge, 1997) . Upon activation, Src is autophosphorylated at tyrosine residue 416 (419 in humans). Critical for the regulation of Src is phosphorylation of tyrosine 527, within the negative regulatory element. A phosphorylated tyrosine residue at 527 leads to an intramolecular interaction with the SH2 domain of Src, and promotes an intramolecular SH3 domainmediated interaction, which inhibits catalytic activity (Roussel et al., 1991; Bibbins et al., 1993; Liu et al., 1993; Xu et al., 1997 Xu et al., , 1999 . V-Src is a constitutively active form of Src, lacking several amino acids at the carboxy-terminus, notably the tyrosine at position 527. Detailed mechanisms regarding regulation of Src kinases are found elsewhere in this issue.
SFKs have been implicated in controling signal transduction downstream of a variety of cell surface receptors including the integrins. The integrins are transmembranous heterodimeric receptors comprised of an a subunit noncovalently associated with a b subunit (Giancotti and Tarone, 2003) . There are 18 known a subunits and eight identified b subunits, and different ab combinations function as distinct receptors. Ligands present in extracellular spaces and basement membranes such as vitronectin, fibronectin, laminin and collagen are recognized by specific integrins such as a5b1 (which recognizes fibronectin) (Jin and Varner, 2004) . It should be noted that some integrins can interact with several different extracellular matrix (ECM) proteins, for example, avb3 can bind at least six different ECM proteins, including vitronectin and fibrinogen. Many integrins recognize the tripeptide Arg-Gly-Asp or other short peptide sequences EILDV (Jin and Varner, 2004) . In addition, some integrins bind to coreceptors on the surface of other cells, for example, ICAM-1 and VCAM-1. Besides performing an adhesive function, ligation of ECM proteins to integrins leads to transduction of intracellular signals, including activation of tyrosine kinases and tyrosine phosphorylation of downstream substrates. Signaling events controlled by integrins regulate important biological processes, such as cell migration and cell survival Giancotti and Tarone, 2003) .
This review focuses on the mechanisms of integrin signaling to the actin cytoskeleton, in particular on the role of SFKs. The evidence implicating SFKs in the control of the biological processes of cell spreading, motility and apoptosis is described. We also discuss how these processes may be deregulated in cancer.
Src and integrin in cancer
The observation that a mutated form of Src in chickens could lead to cell transformation prompted the question whether elevated Src activity played a role in the pathology of human cancers. Indeed, many human tumors exhibit elevated Src kinase activity (Irby and Yeatman, 2000) . Increased Src activity has been found, for example, in human mammary carcinomas, colon cancer and pancreatic cancer (Jacobs and Rubsamen, 1983; Rosen et al., 1986; Ottenhoff-Kalff et al., 1992; Talamonti et al., 1993; Termuhlen et al., 1993; Maa et al., 1995; Verbeek et al., 1996; Mao et al., 1997; Egan et al., 1999; Hakak and Martin, 1999; Harris et al., 1999; Shimakage et al., 2000) . The increased Src kinase activity in these tumors has been proposed to be due to tyrosine phosphatase-mediated dephosphorylation of the carboxy-terminal negative regulatory element, an increase in Src protein levels and/or altered protein stability, an increase in upstream receptor tyrosine kinase activity, or loss of key regulatory proteins (Maa et al., 1995; Mao et al., 1997; Egan et al., 1999; Hakak and Martin, 1999; Harris et al., 1999; Shimakage et al., 2000; Masaki et al., 2003) . A few human colon cancers exhibit Src activating mutations (Irby et al., 1999) . The observation that Src expression increases with the progression of disease suggested that Src may be more active in invasion and metastasis than in tumor formation Termuhlen et al., 1993; Iravani et al., 1998; Masaki et al., 2003) . However, overexpression of Src in colon cancer cells with low metastatic potential was found to increase the growth of the primary tumor without an increase in metastasis . In addition, reducing Src protein expression in HT29 colon cancer cells has been found to suppress cell proliferation in vitro and in vivo (Staley et al., 1997) . Perhaps at an early stage in tumorigenesis, basal Src activity results in cell growth of the tumor, whereas at later stages increased Src activity facilitates metastasis. In support of this, Matsumoto et al. generated transgenic mice with Src expression targeted to the epidermis. Whereas expression of a constitutively activated human Src mutant induced severe epidermal hyperplasia in all animals, only 25% of the animals expressing wild-type Src generated an equally severe phenotype. However, transgenic mice expressing wild-type Src were shown to have an increased susceptibility to tumor-promoting agents . Moreover, the squamous cell carcinoma that formed upon treatment with tumor promoters exhibited an enhanced propensity for metastasis . So, at least in this model, increased Src expression has a role in tumor promotion with elevated activity of the kinase contributing to metastasis.
The effect of increased Src activity in cells appears to be pleiotropic. Cells with elevated Src kinase activity exhibit altered cell-cell adhesion, apoptosis, angiogenesis and tumor cell growth and invasion. Src-transformed cells are particularly characterized by a loss of actin reorganization and reduced cell-ECM adhesion leading to cell rounding and occasional cell detachment (Fincham et al., 1995 (Fincham et al., , 1999 Jones et al., 2002) . In addition, Src-mediated transformation of epithelial cells alters the known cuboidal cell shape to one resembling a fibroblast in a process known as epithelial-mesenchymal transition (or EMT) (Frame, 2004) .
Alterations in integrin activity have been found in several tumor types. For example, increased integrin avb3 and a6b4 expression has been associated with increased cell invasion and metastasis in melanoma and breast carcinomas, respectively (Gehlsen et al., 1992; Nip et al., 1992; Mercurio et al., 2001; Ramos et al., 2002) . Moreover, alterations in integrin activity have been shown to influence the angiogenic potential of endothelial cells. Integrins avb3 and a5b1 have been found to be highly upregulated on angiogenic vessels (Brooks et al., 1994; Kim et al., 2000) . In contrast, a second study showed that the loss of b3 or b5 integrin promotes tumor angiogenesis (Reynolds et al., 2002) . The apparent discrepancies in the role of integrins during angiogenesis have been addressed by Cheresh and Stupack (2002) . Downstream signaling events undoubtedly play an important role in these integrindependent changes in biological activity. Thus there is considerable interest in the role of downstream components of these signaling pathways, including SFKs, in the control of functions related to invasion and metastasis. A major focus of this review is upon the biochemical pathways and biological processes controlled by Src that may contribute to these malignant phenotypes when aberrantly regulated.
Src and integrin signaling
When integrins engage their extracellular ligands, they cluster and cocluster a number of cytoskeletal proteins at regions of close contact with the substrate called focal adhesions. Among the first clues that Src was involved in integrin signaling was the observation that v-Src localized to podosomes, cytoskeletal structures located basally in the cell that are distinct from focal adhesions (Rohrschneider, 1980) . In these original experiments, vSrc was not found in focal adhesions as these structures do not exist in cells highly transformed by v-Src. A compelling demonstration of the localization of v-Src to focal adhesions was demonstrated using a temperaturesensitive mutant (Fincham et al., 1996) . Shifting to permissive temperature resulted in dramatic relocalization of v-Src to focal adhesions prior to manifestation of the morphological changes associated with transformation by v-Src. Various forms of activated Src have been clearly observed in focal adhesions. A Src mutant defective for phosphorylation of the negative regulatory element can localize to focal adhesions as can Src expressed in cskÀ/À fibroblasts, which is hypophosphorylated at tyrosine 527 (Howell and Cooper, 1994; Kaplan et al., 1994) . Further, the amino-terminal half of Src localizes to focal adhesions when expressed in fibroblasts. The SH3 domain is critical for the localization of both activated Src and v-Src to focal adhesions (Kaplan et al., 1994; Fincham et al., 1996) . In addition, relocation of Src to focal adhesions was shown to be RhoA and probably ROCK (Rho kinase) dependent (Timpson et al., 2001) .
In contrast to the localization of activated Src to focal adhesions, localization of nonactivated Src is primarily perinuclear and in endosomes (Seidel-Dugan et al., 1992; Kaplan et al., 1994; Schaller et al., 1999; Timpson et al., 2001) . The predominant localization of Src to these other compartments suggests that a small fraction of the total Src is localized to focal adhesions or that Src is transiently localized to these structures. Upon cell adhesion, a relocalization of a fraction of the total cellular Src to focal adhesions has been reported (Kaplan et al., 1995) , whereas other reports have not observed this alteration in localization (Cary et al., 2002) .
A second line of evidence suggesting that Src functions in integrin signaling came from the identification of tyrosine-phosphorylated substrates in Srctransformed cells. These included focal adhesion kinase (FAK), p130 CAS and paxillin (Glenney and Zokas, 1989; Kanner et al., 1990) . In addition, each of these proteins was shown to associate with Src in vivo. Characterization of these proteins since their discovery revealed that each is a major component of an integrin-dependent signaling pathway. As these Src substrates and binding proteins function in integrin signaling, it appeared likely that a normal function of Src included regulation of signaling events downstream of the integrins.
Following up on these lines of investigation, pharmacological and genetic approaches have conclusively established SFKs as regulators of integrin signaling. One or more of these kinases function in the transduction of biochemical signals downstream of the integrins. Further SFKs play essential roles in the control of multiple integrin-dependent biological processes. While SFKs function in integrin signaling and control of the actin cytoskeleton in many cell types, we will predominantly focus upon the function of these proteins in fibroblasts and epithelial cells, with a few select examples describing other systems.
The focal adhesion kinase -an important SFK binding partner FAK was first identified as a tyrosine-phosphorylated protein and Src-associated protein, in v-Src-transformed cells (Kanner et al., 1990) . At the amino-terminus of FAK is a FERM domain, which is homologous to domains found in the JAK family kinases as well as ezrin, radixin and moesin (Girault et al., 1999) . FERM domains have been shown to interact directly with the cytoplasmic domains of transmembrane receptors and also facilitate intramolecular interactions (Mangeat et al., 1999) . Likewise, the FERM domain of FAK has been shown to bind to peptides mimicking the cytoplasmic domain of integrin b tails in vitro and co-immunoprecipitate with growth factor receptors Danker et al., 1998; Sieg et al., 2000; Golubovskaya et al., 2002) . Recent evidence for an intramolecular interaction has also been published . The central region of FAK contains the catalytic domain. Between the FERM and catalytic domains is tyrosine 397, which is the major autophosphorylation site of FAK (see below). At the carboxy-terminus is a 150-amino-acid region termed the 'focal adhesion targeting' or FAT domain. As the name suggests, this domain is essential for localization of FAK to sites of cell-ECM adhesion. Mutants of FAK unable to localize to focal adhesions are not appropriately regulated upon cell-ECM adhesions (Shen and Schaller, 1999; Cooley et al., 2000) . Located between the catalytic and FAT domains are two proline-rich sequences (PR1 and PR2), which mediate interactions with Src homology (SH3) domain-containing proteins, including p130
CAS (Polte and Hanks, 1997) . FAK colocalizes with integrins in focal adhesions. Tyrosine phosphorylation of FAK and its catalytic activity are stimulated upon integrin-dependent cell adhesion. It is unclear exactly how clustering of integrins leads to activation of FAK. Perhaps the clustering of integrins at sites of cell adhesion, with the subsequent localization of FAK molecules in close proximity, may lead to intermolecular tyrosine phosphorylation (Polte and Hanks, 1997; Toutant et al., 2002) . Alternatively, conformational changes in FAK upon integrin binding may expose phosphorylation sites or sequestration from tyrosine phosphatases (Hanks et al., 2003) . SFKs may also play an important role in tyrosine phosphorylation and activation of FAK upon cell adhesion (see below).
Autophosphorylation of FAK creates a high-affinity binding site for the SH2 domain of Src (Schaller et al., 1994) . In addition, there is a proline-rich sequence upstream of the autophosphorylation site of FAK that conforms to a high-affinity binding site for the SH3 domain of Src (Thomas et al., 1998) . Thus the interaction between FAK and Src may be mediated by both SH2 and SH3 domain-mediated interactions. Cell adhesion promotes association between SFKs and FAK (Schlaepfer and Hunter, 1996) , and many of the biological processes that are regulated by FAK are also regulated by Src (see below). These observations suggest that FAK is an important partner for SFKs in controlling responses triggered by integrin-dependent cell adhesion.
How is Src activated upon integrin stimulation?
The catalytic activity of Src upon integrin-dependent adhesion has been examined. Some studies report an increase in catalytic activity, albeit a weak activation (2-3-fold increase), yet others have not observed a change in Src activity upon adhesion (Kaplan et al., 1995; Schlaepfer et al., 1998; Schaller et al., 1999; Maher, 2000; Cary et al., 2002) . The discrepancy between these studies has not been resolved; however, the low level of activation may reflect activation of a small fraction of the total Src within the cell. Regardless, SFK activity is required for integrin-dependent signaling events. Consequently, perturbation of proteins that regulate SFKs will affect integrin signaling pathways.
As described above, SFKs are negatively regulated by phosphorylation of a carboxy-terminal tyrosine residue (527 in chicken). This phosphorylation is catalyzed by the tyrosine kinase Csk (c-Src terminal kinase) (Cooper et al., 1986; Okada and Nakagawa, 1989) . This modification promotes an intramolecular interaction between the carboxy-terminus of Src and its SH2 domain and an SH3 domain-mediated intramolecular interaction leading to a closed conformation and inactivation of the protein (Thomas and Brugge, 1997; Xu et al., 1997 Xu et al., , 1999 . To facilitate interaction with effector substrates via its SH2 and SH3 domains, it is clear that Src protein has to be released from its inactive conformation. Several mechanisms of Src regulation have been proposed, including regulation of phosphorylation of the negative regulatory element by Csk, dephosphorylation of this residue by antagonistic phosphatases and disruption of the intramolecular inhibitory interactions by engagement of the Src SH3 and SH2 domains with high-affinity intermolecular ligands (Figure 1 ).
Dephosphorylation of Src Y527
Dephosphorylation of Y527 by protein tyrosine phosphatases (PTPs) is a likely mechanism to activate Src. The most likely tyrosine phosphatase involved in response to cell adhesion is the transmembrane phosphatase PTPa . Downregulation of Src and Fyn kinases has been observed in ptpaÀ/À cells, which correlated with enhanced tyrosine phosphorylation of the negative regulatory element (Ponniah et al., 1999) . These fibroblasts lacking PTPa also exhibit defective tyrosine phosphorylation of substrates for cell adhesion-induced tyrosine phosphorylation (Ponniah et al., 1999; Su et al., 1999; Zeng et al., 2003) . PTPa overexpression has been shown to activate Src in vivo and induce cellular transformation (den Hertog et al., 1993; Zheng et al., 2000) . Furthermore, PTPa-overexpressing cells show increased tyrosine phosphorylation of focal adhesion-associated proteins (Harder et al., 1998) . Structural analysis indicates a direct interaction between the Src SH2 domain and the D2 domain of PTPa (Sonnenburg et al., 2003) . This interaction may disrupt the intramolecular inhibitory interactions within Src, thus exposing the carboxy-terminal Y527 for dephosphorylation. Catalytically inactive but not wildtype PTPa was found to localize to focal adhesions (Lammers et al., 2000) . These findings suggest a model where the transient interaction of Src with PTPa at focal adhesions would lead to carboxy-terminal Src dephosphorylation and translocation of Src to its focal adhesion-associated binding partners.
A second PTP that may regulate Src in response to cell adhesion is PTP1B. Overexpression of a catalytically defective mutant of PTP1B in mouse L cells reduces Src activity when the cells are plated on fibronectin (Arregui et al., 1998) . Furthermore, these cells also showed reduced levels of tyrosine phosphorylation of focal adhesion proteins that become tyrosine phosphorylated upon cell adhesion. PTP1B was also co-immunoprecipitated with b1 integrin and colocalized with integrins at focal adhesions (Arregui et al., 1998) . PTP1B has also been purified and identified from breast cancer cells as a phosphatase that could dephosphorylate a peptide containing phosphotyrosine 527 (Bjorge et al., 2000) . It has been well described that a third tyrosine phosphatase, Shp2, plays a role in integrin signaling. For example, shp2À/À cells have deficiencies in cell spreading and motility with increased numbers of immature focal adhesion complexes (Oh et al., 1999; von Wichert et al., 2003a) . Originally, shp2À/À cells were shown to exhibit enhanced tyrosine phosphorylation when cells were taken into suspension, suggesting that Shp2 regulated dephosphorylation of cell adhesiondependent phosphoproteins (Yu et al., 1998) . Further studies revealed defective phosphorylation of focal adhesion-associated proteins upon cell adhesion and this defect was ascribed to a failure to activate SFKs (Oh et al., 1999) . A Shp2 binding partner, SHPS-1, becomes tyrosine phosphorylated in an Src-dependent manner upon cell adhesion and recruits Shp2 into complex (Tsuda et al., 1998; Oh et al., 1999) . This was proposed to be a positive feedback mechanism where active Src could recruit Shp2 in order to activate additional molecules of Src.
Shp2 was presumed to regulate SFKs by direct dephosphorylation of the negative regulatory element. However, recent exciting data have suggested a novel mechanism. Shp2 contributes to SFK activation by controling access of Csk to Src kinases via the Csk regulator PAG/Cbp (Zhang et al., 2004) . In response to integrin signaling, cells devoid of Shp2 exhibit hyperphosphorylated PAG. This was shown to lead to sustained localization of Csk at focal adhesions (Zhang et al., 2004) . Hence, shp2À/À cells exhibit hyperphosphorylated Src carboxy-terminal tyrosine residues (Zhang et al., 2004) . A separate study has indicated that EGF stimulation induces Shp2-dependent dephosphorylation of paxillin and dissociation of Csk from the paxillin-Src complex, leading to Src activation (Ren et al., 2004) . Given that paxillin, a focal adhesioncontaining protein, is involved in the EGF-mediated regulation of Src kinase activity may indicate a mechanism of Src activation via crosstalk between integrin-and growth factor-mediated signaling pathways.
Competitive inhibition
A second possible mechanism of Src activation may be via ligand competition between proteins containing highaffinity SH2/SH3 ligands and the low-affinity intramolecular binding sites for the SH2 and SH3 domains within Src. The interaction between Src and an SH2-or SH3-binding site on another protein would relieve the intramolecular, inhibitory interactions on Src and activate the protein. FAK, paxillin and p130 CAS are three proteins, found in focal adhesions that also contain Src SH3-and SH2-binding sites. In the case of FAK and p130 CAS , these high-affinity docking sites are located in close proximity. FAK and Sin-1 (a p130 CAS -related protein) have been shown to activate Src by disruption of the intramolecular inhibitory interactions, and the most potent activation occurs when the SH2 and SH3 inhibitory interactions are simultaneously disrupted (Alexandropoulos and Baltimore, 1996; Thomas et al., 1998; Walter et al., 1999) . This could be a primary mechanism of activation, but the evidence presented above clearly establishes a critical role for PTPs in regulating Src. Docking with these cytoskeletal proteins might also serve to stabilize SFKs in the active conformation following initial activation by phosphatases.
Direct interaction of Src with integrins
Recent data have demonstrated that in platelets, Src may be co-immunoprecipitated with the b3 subunit of the fibrinogen receptor (Obergfell et al., 2002; AriasSalgado et al., 2003) . Furthermore, upon adhesion, the Src co-immunoprecipitating with integrin is activated (Obergfell et al., 2002; Arias-Salgado et al., 2003) . The Src-integrin interaction was mediated by the SH3 domain of Src and this interaction was specific for the b3 subunit. Interestingly, Csk was also found to co-immunoprecipitate with b3 from platelets in suspension (Obergfell et al., 2002) . However, upon platelet adhesion to fibrinogen, Csk was found to dissociate from b3, which correlated with the recovery of active Src in complex with the integrin (Obergfell et al., 2002) . Hence, Src may be regulated by a combination of mechanisms in this scenario. First, loss of Csk from the complex may enhance activation by phosphatases and second, clustering of integrins would result in coclustering of associated Src molecules, potentially promoting transphosphorylation and activation. Although the direct binding of Src to integrin b tails currently appears unique to platelet-specific integrins, it has offered an intriguing novel mechanism for the activation of Src by integrins.
Biological processes mediated by Src-integrin signaling
Src and the regulation of cell adhesion, spreading and motility SFKs are required for the efficient adhesion and spreading of a variety of cell types on integrin ligands. srcÀ/À fibroblasts exhibit reduced adhesion and delayed spreading relative to Src-expressing fibroblasts (Kaplan et al., 1995; Felsenfeld et al., 1999) . Osteoclasts isolated from srcÀ/À mice show reduced adhesion and spreading on vitronectin (Lakkakorpi et al., 2001) . Both pharmacological approaches and studies using Jurkat cell lines defective for Lck expression have indicated that this SFK functions in regulating adhesion of T cells to ICAM or VCAM1 (Feigelson et al., 2001; Fagerholm et al., 2002) . Src has also been implicated in regulating adhesion of epithelial cells to fibronectin from studies using cell lines as a model for progression of cancer cells to metastatic cells . Pharmacological inhibition of SFK impaired adhesion, while exogenous expression of activated Src promoted cell adhesion. Thus regulation of cell adhesion and spreading appears to be a general feature of SFKs.
In fibroblasts, impairment of FAK signaling also inhibits cell spreading. FakÀ/À fibroblasts show delayed spreading, as do primary fibroblasts expressing a dominant-negative FAK mutant called FRNK (Richardson and Parsons, 1996; Owen et al., 1999) . Reconstitution of fakÀ/À cells with wild-type FAK has been shown to rescue the spreading and morphological defect, while overexpression of wild-type FAK can rescue the spreading defect in cells expressing FRNK.
The FAK397F mutant cannot rescue these defects. Furthermore, Src overexpression in FRNK-expressing fibroblasts has been shown to enhance cell spreading in fibroblasts expressing FRNK (Richardson et al., 1997) . These results suggest that the FAK/SFK complex may function in the control of cell spreading.
Several lines of evidence have implicated PTPs in the regulation of integrin-mediated cell spreading. For example, ptpaÀ/À cells and shp2À/À fibroblasts exhibit a delay in cell spreading on fibronectin (Oh et al., 1999; Su et al., 1999) . In addition, overexpression of a dominant-negative mutant of PTP1B in mouse L cells impairs cell spreading on fibronectin (Arregui et al., 1998) . As described above, a target for these PTPs is Src and the spreading phenotype when these phosphatases are inhibited is similar to the srcÀ/À phenotype. Thus these phenotypes are likely a consequence of impaired activation of SFKs in these cells.
Cell adhesion and protrusion, as occurs in cell spreading, are required events for cell migration. One of the phenotypes acquired by v-Src-transformed cells is an increase in cell motility (Frame, 2004) . Endogenous Src also functions in the control of cell motility as SYF cells exhibit impaired migration (Klinghoffer et al., 1999) . Notably, SYF cells are defective for haptotaxis, which is migration in response to a gradient of ECM proteins and is controled by signaling pathways downstream of integrins. Cells expressing kinase-inactive Src have also been shown to exhibit migratory defects (Fincham et al., 1996) .
Evidence that FAK had a positive influence on cell motility came from several sources. FAK was found to be upregulated in keratinocytes during migration to repair an epidermal burn wound (Gates et al., 1994) . Integrin-dependent motility of CHO cells is enhanced upon FAK wild-type overexpression, while expression of a dominant-negative FAK mutant in endothelial cells or fibroblasts has been shown to inhibit cell motility (Cary et al., 1996; Gilmore and Romer, 1996; Richardson et al., 1997) . Fibroblasts derived from fakÀ/À embryos exhibited reduced motility compared to cells derived from wild-type embryos (Ilic et al., 1995) . The motility of fakÀ/À cells was restored upon re-expression of wild-type FAK Sieg et al., 1999) . From both overexpression studies and studies using FAK mutants to rescue the motility defect of fakÀ/À cells, the autophosphorylation site/SH2-binding site at tyrosine 397 and PR1 sequences of FAK, which is the major docking site for p130 CAS , were shown to be essential for the integrin-mediated migration (Cary et al., 1998; Sieg et al., 1999) . Thus SFKs may be important components of the signaling pathway by which FAK controls cell motility.
Src and focal adhesion turnover
Pharmacological studies had initially implicated tyrosine kinases in controling the assembly of focal adhesions and SFKs were logical candidates to function in this role. Most recent evidence suggests that SFKs are not essential for focal adhesion assembly as fibroblasts deficient in Src, Fyn and Yes kinases (SYF) exhibit normal focal adhesions (Klinghoffer et al., 1999; Volberg et al., 2001) . However, in one case, there is evidence that SFKs might influence the assembly of complexes very early after cell attachment. Very shortly after adhesion to matrix, GFP-paxillin is assembled into small complexes in wild-type but not SYF fibroblasts . Re-expression of Src or Yes did not rescue this defect, but re-expression of Fyn did rescue this defect. This effect was dependent upon avb3 regardless of whether adhesion to fibronectin or vitronectin was examined. This observation is interesting as it suggests differential roles of SFKs during adhesion.
Cell migration on an ECM is not able to take place in the absence of focal adhesion turnover since retraction at the rear of the cell will not occur. FakÀ/À cells, which have decreased motility compared with FAK-expressing fibroblasts, have larger focal adhesions (Ilic et al., 1995) . This focal adhesion phenotype has clearly been established to be a consequence of reduced focal adhesion turnover (Ren et al., 2000; Webb et al., 2004) . SFK are likely to function in concert with FAK to control focal adhesion disassembly. The 397F mutant of FAK, which cannot bind Src, is unable to promote focal adhesion disassembly when re-expressed in a fakÀ/À background, whereas wild-type FAK re-expression restores normal focal adhesion disassembly. Further, pharmacological inhibition of SFKs reduces focal adhesion turnover and the SYF fibroblasts also exhibit impaired adhesion turnover . These recent findings are consistent with other evidence suggesting that Src might function in regulating focal adhesions. Expression of the amino-terminal half of Src or kinase-defective v-Src in fibroblasts produces larger focal adhesions. This likely reflects inhibition of endogenous SFKs and impairment of focal adhesion turnover (Kaplan et al., 1994; Fincham and Frame, 1998) . Interestingly, srcÀ/À osteoclasts exhibit a defect in the assembly of adhesion structures. While wild-type osteoclasts adhere to vitronectin and assemble podosomes, srcÀ/À osteoclasts fail to form podosomes on ECM, instead forming focal adhesions (Sanjay et al., 2001b) . From these observations, it has been suggested that Src functions in the remodeling of focal adhesions into podosomes to promote motility of osteoclasts (Sanjay et al., 2001b) .
Calpains are a family of calcium-dependent cysteine proteases, which have been shown to play a role in cell motility (Huttenlocher et al., 1997) . Inhibition of calpain has been shown to cause impaired retraction at the rear of the cell (Palecek et al., 1998) . The observation that calpain molecules colocalized with focal adhesion proteins suggested that the cleavage of focal adhesioncontaining proteins by calpains may play a role in focal adhesion disassembly (Beckerle et al., 1987) . Indeed, upon v-Src-mediated transformation, FAK was shown to be cleaved in a calpain-dependent manner (Carragher et al., 2001 (Carragher et al., , 2002 . In a later study, a complex between FAK, ERK kinase and calpain 2 was observed to assemble in the presence of activated Src (Carragher et al., 2003) . In this scenario, FAK kinase activity was found to be dispensable for the interaction, but the interaction depended on the proline-rich sequence on FAK that binds the Src SH3 domain (Carragher et al., 2003) . FAK was required for recruitment of calpain to focal adhesions and for maximal calpain activity in cells as calpain localization to focal adhesions and total cellular activity was severely reduced in fakÀ/À cells (Carragher et al., 2003) . Taken together, these studies have indicated a biochemical pathway involved in the proteolytic turnover of FAK (and probably other proteins) and disassembly of focal adhesions that may be controlled by Src.
Control of integrin attachment to the cytoskeleton
SFKs have also been implicated in controling attachment of integrins to the cytoskeleton. When matrixcoated beads are applied to cells they attach to the surface via integrins. Application of force to the bead using a laser trap can result in increased tethering of the integrin to the actin cytoskeleton, which can be measured by the increased force required to trap the same bead a second time. This strengthening of the integrin/cytoskeleton attachment has been called reinforcement. In control cells, the interaction of the vitronectin receptor with the cytoskeleton is reinforced. In contrast, the vitronectin receptor becomes reinforced in srcÀ/À fibroblasts (Felsenfeld et al., 1999) . These results suggest that Src functions in inhibiting reinforcement of the vitronectin receptor.
In ptpaÀ/À fibroblasts, fibronectin and vitronectin receptors exhibit reduced tethering to the actin cytoskeleton. Using matrix-coated beads to measure movement of the integrins on the cell surface, these integrins were found to diffuse three times faster in the ptpaÀ/À cells (von Wichert et al., 2003b) . Application of force to the beads using a laser trap promoted recruitment of GFPpaxillin around the beads in wild-type cells but not in ptpaÀ/À fibroblasts (von Wichert et al., 2003b) . This result seems paradoxical given the evidence that Src inhibits reinforcement. Overexpression of Fyn rescues this defect in ptpaÀ/À cells, whereas overexpression of other SFKs does not. Thus one explanation is that Src and Fyn function differently, one to inhibit and the other to promote reinforcement. Alternatively, it is possible that the ptpaÀ/À cells exhibit more pleiotropic effects due to the disruption of additional signaling pathways besides regulation of SFKs.
Role of Src kinases in the assembly of fibronectin matrix
The ECM is highly organized. Fibronectin, for example, is secreted and deposited extracellularly, and then reorganized into fibronectin fibrils. Cells embedded in the matrix play an active role in the assembly of fibronectin fibrils, and binding of fibronectin by cell surface integrins is critical for assembly of the fibronectin matrix (Wierzbicka-Patynowski and Schwarzbauer, 2003) . Src family kinases have been implicated in this process from the results of two lines of investigation. First, SYF cells exhibit a defect in the assembly of fibronectin into an insoluble matrix and this defect is rescued upon re-expression of Src (Wierzbicka-Patynowski and Schwarzbauer, 2002) . Second, pharmacological inhibition of Src family kinases also impairs the assembly of a fibronectin matrix (Wierzbicka-Patynowski and Schwarzbauer, 2002) . Interestingly, fakÀ/À fibroblasts similarly exhibit a defect in fibronectin matrix assembly (Ilic et al., 2004) . This defect can be rescued by re-expression of wild-type FAK, but not by FAK397F, nor by a FAK mutant that is impaired for binding p130 CAS (Ilic et al., 2004) . Together these findings suggest that the FAK/SFK complex may be the active signaling component promoting assembly of the fibronectin matrix and that p130 CAS may be an important downstream effector for this function. The molecular mechanism by which SFKs and FAK might function to control fibronectin assembly remains to be elucidated. One mechanism could be through regulation of the integrin binding fibronectin. A second mechanism could be via regulation of the actin cytoskeleton, as the integrity of the actin cytoskeleton and contractility are required for remodeling fibronectin into a fibrillar matrix (Wierzbicka-Patynowski and Schwarzbauer, 2003) .
Integrin/Src signaling in apoptosis
Loss of cell attachment to the ECM causes apoptosis, a process known as 'anoikis' (reviewed in Frisch and Screaton, 2001 ). Once a cell has begun to metastasize, it has acquired resistance to anoikis, hence it is likely that this resistance involves aberrant integrin signaling independent of cell adhesion. Many studies have indicated that several different integrins have an important role in cell survival (Grossmann, 2002) . In addition, a few studies have implicated FAK and Src in protection from 'anoikis' (Frisch et al., 1996; Hisano et al., 2003) . Of particular interest is the observation that PI-3 kinase, a known regulator of apoptotic protection downstream of growth factor receptor signaling (Vivanco and Sawyers, 2002) , has been shown to bind to a phosphorylated tyrosine 397 of FAK (Chen et al., 1996) . Expression of a constitutively active, membrane-bound FAK (CD2/FAK) confers resistance to anoikis in MDCK cells (Frisch et al., 1996) . The observation that intact kinase activity and tyrosine 397 of FAK are required for protection from apoptosis maintained the possibility that PI-3 kinase-mediated pathways were involved (Frisch et al., 1996) . As tyrosine 397 is also the SFK-binding site, it is also possible that SFKs participate in this process. In a second study, detachment of mammary epithelial cells from ECM induced a rapid translocation of the proapoptotic protein Bax to mitochondria (an intermediate process during apoptosis) in a FAK-dependent manner (Gilmore et al., 2000) . The mitochondrial translocation of Bax is induced by expression of a FAK dominantnegative mutant (Gilmore et al., 2000) . This effect of dominant-negative FAK could be overcome by PI3-kinase or Src overexpression (Gilmore et al., 2000) . These observations suggest that a signal transmitted through FAK, Src and PI3-kinase functions to impair mitochondrial translocation of Bax and thus block apoptosis when cells are adherent.
The role of Src in protection from anoikis has been supported from studies in human tumor lines (Windham et al., 2002) . Expression of activated Src in human colorectal cancer cells (SW480) leads to increased resistance to anoikis (Windham et al., 2002) . The changes in the Src-mediated response to anoikis were reflected by alterations in Akt phosphorylation (Windham et al., 2002) . A recent study has suggested that activated Src plays a role in adhesion-dependent apoptosis in breast cancer cell lines, acting downstream of FAK and leading to the Src-mediated upregulation of a2 integrin (Park et al., 2004) . Taken together, the results described above suggest that activated Src or FAK protects cells from anoikis likely via Akt-mediated pathways. It should be noted however that there are other signaling pathways through which FAK may also Figure 3 Biochemical reactions at the front and the rear of the cell are critical for cell migration. SFKs regulate spreading (protrusion) and focal adhesion disassembly, events important for motility. An Src-autophosphorylated FAK complex leads to Src-dependent phosphorylation of FAK (1) and p130 CAS (2). The binding of c-Crk to p130 CAS activates Rac and Cdc42, via translocation of the Rac activator DOCK1 (3). Active Rac and Cdc42 promote protrusion at the leading edge of the cell via WASP/WAVE-dependent activation of the Arp2/3 complex (4). At the rear of the cell, focal adhesion disassembly and cell-substrate detachment occurs leading to retraction of the tail of the cell. Upon v-Src-mediated transformation (and possibly Src during normal cell migration) (5), a complex between FAK, ERK kinase and calpain 2 assembles leading to cleavage of FAK in a calpain-dependent manner (6) control cells survival (Ilic et al., 1998; Almeida et al., 2000) .
Biochemical pathways involved in Src-mediated cell motility (Figures 3 and 4) Interplay between SFKs and FAK As mentioned above, FAK undergoes autophosphorylation on tyrosine residue 397 upon cell adhesion. This leads to the recruitment of SH2 domain-containing proteins such as Src (Figure 2) . SFK binding to FAK is proposed to disrupt the intramolecular interaction between the Src SH2 domain and the negative regulatory carboxy-terminal Y527, leading to increased Src catalytic activity or alternatively to stabilize SFKs in their active conformation. The binding of Src with FAK at tyrosine 397 leads to phosphorylation of the remaining sites of tyrosine phosphorylation in FAK, namely Y407, 576, 577, 861 and 925 (Schaller et al., 1994; Schlaepfer et al., 1994; Calalb et al., 1995 Calalb et al., , 1996 (Figures 2 and 3) . In SYF mouse embryo fibroblasts, very little tyrosine phosphorylation of any proteins, including FAK, upon integrin stimulation is observed (Klinghoffer et al., 1999) . The mechanistic details of the regulation of FAK phosphorylation by Src were revealed in a recent study (Cary et al., 2002) . First, the interaction between Src and FAK was inhibited by an Src SH2 or SH3 domain mutation. It should be noted that intramolecular Src interactions were not disrupted by these particular SH2 and SH3 changes. Second, Src kinase activity was not required for FAK autophosphorylation, which suggests a scaffolding function for Src in this context (Cary et al., 2002) . Third, Src kinase activity, but not the Src SH2 or SH3 domain, is required for phosphorylation at the remaining five sites of tyrosine phosphorylation in FAK (Cary et al., 2002) . Finally, expression of a Src mutant, deficient for autophosphorylation (murine Y416), could rescue FAK phosphorylation upon adhesion to fibronectin (Cary et al., 2002) . From this data, it is puzzling how Src is able to phosphorylate FAK despite lacking the two proposed FAK-binding sites (SH2 and SH3). The authors reconcile this idea by suggesting that there may be some remaining weak association between the SH2 domain Src mutant (T215W) and FAK (Cary et al., 2002) . Alternatively, transient activation/localization of SFK in proximity with FAK in focal adhesions might promote FAK phosphorylation independently of direct binding to FAK. In fact, v-Src has also been reported to phosphorylate FAK without assembly of the FAK/Src 
FAK

Src
Focal Adhesion Turnover Figure 4 Integrin-mediated biochemical pathways involved in cell migration. Evidence suggests that integrin-mediated regulation of cell motility is complex. Key players include Src family kinases and FAK. The figure shows the biochemical pathways implicated in integrin-Src-dependent regulation of cell motility. Evidence suggests that the effect of v-Src on cell migration may be mediated by increased focal adhesion turnover and increased MMP-2 production via a Crk-DOCK180-Rac-JNK pathway complex, further supporting this mechanism (McLean et al., 2000) . Tyrosine residues Y576 and 577 are located in the kinase domain activation loop of FAK. Phosphorylation of these tyrosine residues is likely required for maximum FAK catalytic activity (Calalb et al., 1995; Owen et al., 1999) . In addition to regulation by SFKs, normal phosphorylation of tyrosines 576 and 577 may be regulated by tyrosine phosphatases given the observation that vanadate treatment of fibroblasts leads to sustained Y576 and 577 phosphorylation (Maa and Leu, 1998) . The consequence of increased Y407 and Y861 of FAK upon cell adhesion is not completely understood. Tyrosine phosphorylation of these residues has been observed in mouse epithelial cells undergoing EMT . Perhaps these residues are involved in recruiting substrates transiently involved in regulating motility during the normal processes of embryonic development or abnormally in tumor metastasis. In addition, a rapid increase in tyrosine 861 phosphorylation of FAK has been observed in response to VEGF treatment of cultured endothelial cells or intact mouse tissues (Eliceiri et al., 2002) . Phosphorylation of this FAK residue by VEGF appeared to be critical for interaction with the avb5 integrin in vitro and in vivo (Eliceiri et al., 2002) . Perhaps FAK Y861 is important in the synergistic activation of signaling pathways mediated by growth factors and integrin avb5 in endothelial cells.
Tyrosine 925 resides in the FAT domain of FAK and, in its phosphorylated form, can bind to the SH2 domain of Grb2. Relative to other tyrosine phospho-acceptor sites, tyrosine 925 is a poor substrate for Src, which may be due to occlusion given the close proximity of the binding sites of other FAK binding partners and/or the three-dimensional structure of the domain (Calalb et al., 1995; Arold et al., 2002; Hayashi et al., 2002; Liu et al., 2002) . There is evidence linking Src-dependent phosphorylation of tyrosine 925 and motility of Caco-2 colorectal cancer cells plated on collagen IV (Sanders and Basson, 2004) . In contrast, CHO cells expressing Y925F FAK mutant were found to migrate at a similar rate to wild-type FAK (Cary et al., 1998) . Phosphorylation of this residue may also regulate the localization of FAK to focal adhesions (Katz et al., 2003) .
In addition to SFK binding, FAK autophosphorylation also leads to the recruitment of other SH2 domain containing signaling proteins such as PI3-kinase, Shc, Nck-2, Grb7 and Plcg (Chen et al., 1996; Schlaepfer et al., 1998; Han and Guan, 1999; Zhang et al., 1999; Goicoechea et al., 2002) . The Nck family of proteins have been proposed to play a role in the regulation of the actin cytoskeleton and cell movement (Buday et al., 2002) . The integrin-dependent interaction between FAK and Plcg or PI3-kinase suggests that FAK plays a role in inositol lipid metabolism and phospholipid signaling. A role for Grb7 in FAK-dependent motility has been described recently (Shen and Guan, 2004) .
The observation that FAK can interact with three different 'adaptor' molecules, Shc, Grb7 and Nck-2, which lack kinase activity but can promote downstream signals suggests that FAK may be a central point for crosstalk between many signaling pathways. FAK and/ or Src has been shown to phosphorylate Shc and hence stimulate the Grb2 interaction and activation of the MAP kinase signaling pathway . Thus there are multiple mechanisms linking FAK to the activation of MAP kinase. In addition, there are clearly FAK-independent mechanisms of activating MAP kinase. In this regard, it is interesting to note the MAP kinase activity is required for turnover of focal adhesions .
Role of p130 CAS
FAK is not the sole interacting partner or Src substrate in focal adhesions. p130 CAS was initially identified as an interacting and tyrosine-phosphorylated protein in vSrc-and v-Crk-transformed cells (Mayer et al., 1988; Kanner et al., 1990; Sakai et al., 1994) . p130
CAS is a docking protein consisting of multiple protein interaction domains, including an amino-terminal SH3 domain, an Src-binding domain near the carboxyterminus and multiple SH2 domain-binding sites in a region termed the substrate domain (Sakai et al., 1994; Polte and Hanks, 1995) (Figure 3) . The SH3 domain of p130 CAS has been shown to interact with either of the FAK proline-rich sequences (PR1 and 2) (Polte and Hanks, 1997) . The FAK-p130 CAS interaction and tyrosine phosphorylation of p130 CAS are enhanced upon cell adhesion (Polte and Hanks, 1997; Klemke et al., 1998) . There is evidence suggesting that the FAKp130 CAS interaction is important for cell motility (Figure 3) . A FAK mutant, defective for p130 CAS binding, is also defective for inducing cell migration (Cary et al., 1998; Sieg et al., 1999) . In addition, dominant-negative p130 CAS overexpression was shown to impair the recruitment of endogenous p130 CAS to FAK and reduce cell migration (Cary et al., 1998) . Finally, p130 CAS -deficient fibroblasts exhibit similar motility defects as SYF fibroblasts (Honda et al., 1999) . As the 397F FAK mutant of FAK fails to promote motility and p130 CAS tyrosine phosphorylation, recruitment of p130 CAS and SFKs into complex may be important for promoting p130 CAS phosphorylation and motility (Cary et al., 1998) .
In addition, Src SH2 and SH3 domains have the capability to bind to the carboxy-terminal region of p130 CAS and Src can phosphorylate p130 CAS (Nakamoto et al., 1996; Vuori et al., 1996; Klinghoffer et al., 1999) . However, expression of activated Src lacking its SH2 and SH3 domains has been shown to increase association of FAK with p130 CAS . This suggests that it is likely that the initial phosphorylation of FAK by Src leads to sequential binding of FAK to p130 CAS rather than the formation of a tripartite Src-p130 CAS -FAK complex (Polte and Hanks, 1997) . The efficiency of the Srcinduced p130 CAS phosphorylation reaction is enhanced by the presence of FAK as a scaffold, not as a kinase (Ruest et al., 2001) . Src-mediated phosphorylation of p130 CAS is likely to be important for the recruitment of 
Role of Crk
The viral protein v-Crk was found to interact with p130
CAS
. The cellular counterpart of v-Crk, c-Crk, is an SH2/SH3 domain adaptor protein and has been shown to promote the key downstream signaling events from p130 CAS involved in integrin-mediated cell migration (Klemke et al., 1998) . The binding of c-Crk via one of the nine potential Crk SH2 domain-binding sites on p130 CAS leads to the promotion of downstream signaling events through proteins associated with Crk SH3 domains, such as C3G or DOCK1 (Knudsen et al., 1994; Gotoh et al., 1995; Hasegawa et al., 1996; Kiyokawa et al., 1998) .
The haptotatic response via the Cas-Crk pathway described by Klemke et al. was inhibited by expression of a dominant-negative form of Rac but not Ras (Klemke et al., 1998) . This observation suggested that Rac was a downstream target of integrin signaling. Some excellent recent studies have elucidated the mechanism by which Rac is activated in this pathway. CrkL was targeted to focal adhesions constitutively and independently of tyrosine phosphorylation of focal adhesion substrates by fusion to the focal adhesion targeting sequence of paxillin. Focal adhesion-localized CrkL, but not a variant lacking the amino-terminal SH3 domain, was shown to activate Rac and Cdc42, via translocation of the Rac activator DOCK1 (also known as DOCK180) to focal adhesions. Expression of CrkL at focal adhesions could also overcome the haptotatic defects of SYF fibroblasts . It is believed that Crk and the related CrkL have similar functions (Feller, 2001) . As with SYF, FAK and CAS null cells, CrkL null fibroblasts exhibit impaired integrin-induced migration .
Together, these findings suggest that integrin signaling via Src and FAK leads to the activation of Rac and Cdc42. The Rac-and Cdc42-dependent effector pathways have been well described previously Pollard and Borisy, 2003) . Briefly, Rac and Cdc42 work in concert at the leading edge of cells in the formation of lamellipodia and filopodia, respectively. Rac and Cdc42 activation leads to the activation of the WAVE and WASP family of proteins, in turn promoting activation of the Arp2/3 complex. Activation of the Arp2/3 complex serves to initiate new actin filament formation, forming a branched column, which pushes the leading edge forward (Higgs and Pollard, 2000; Eden et al., 2002; Innocenti et al., 2004) . This is likely a major mechanism by which Src regulates motility in response to integrin signals.
Role of paxillin
Paxillin is another protein found in focal adhesions, which was initially identified as tyrosine-phosphorylated protein in v-Src-transformed cells (Glenney and Zokas, 1989; Turner et al., 1990) . The amino-terminal half of paxillin consists of proline-rich sequences and five copies of an LD motif (Schaller, 2001) . The carboxy-terminal half is comprised of four LIM domains, one of which functions as the major focal adhesion targeting sequence (Schaller, 2001) .
Upon integrin signaling, autophosphorylation and recruitment of FAK to sites of cell-ECM contact lead to phosphorylation of paxillin at tyrosines 31 and 118 (Burridge et al., 1992; Bellis et al., 1995; . SYF fibroblasts exhibit decreased adhesion-dependent tyrosine phosphorylation on paxillin, suggesting that they directly or indirectly control paxillin phosphorylation (Klinghoffer et al., 1999) . These two tyrosine residues both lie in consensus binding motifs for SH2 domain-containing proteins such as Crk (Birge et al., 1993; . The SH2 domain of Src has been shown to associate with paxillin in vitro . Therefore, it is plausible that the paxillin-Crk interaction is an alternative to p130 CAS -Crk signaling pathway leading to Rac/Cdc42 activation.
Interestingly, the c-Jun kinase (JNK) is activated by Rac and has been shown to play a role in cell migration via serine phosphorylation of paxillin (Huang et al., 2004; Minden et al., 1995) . Expression of mutant paxillin that could not be phosphorylated formed focal adhesions and impaired migration (Huang et al., 2004) . In addition, both FAK and Src have been shown to be intermediate signaling proteins in the integrindependent activation of JNK (Oktay et al., 1999) . Perhaps then, integrin signals generate a Rac-dependent positive feedback loop leading to paxillin promoting focal adhesion turnover and motility.
Role of p190RhoGAP
An early event upon integrin engagement is the inactivation of the Rho GTPase in an Src-dependent manner (Richardson et al., 1997; Owen et al., 1999; Arthur et al., 2000; Ren et al., 2000) . Similarly, fakÀ/À fibroblasts fail to decrease Rho activity transiently upon cell attachment (Ren et al., 2000) . Rho GTPases are involved in stress fiber and focal adhesion formation (Ridley and Hall, 1992) . Rho inhibition transiently reduces contractility, thereby allowing Rac-and Cdc42-mediated membrane spreading and ruffling in the early stages of cell migration (Arthur and Burridge, 2001; Cox et al., 2001) . Two different mechanisms may function in inhibition of Rho activity upon cell adhesion.
The observation that Src can phosphorylate p190RhoGAP, resulting in a decrease in GTP-binding capacity of Rho, provided an early indication of a role for Src in the regulation of Rho (Roof et al., 2000; Haskell et al., 2001) . Cell adhesion promotes SFKdependent tyrosine phosphorylation of p190RhoGAP and concomitantly, an activation of p190RhoGAP activity, which may be responsible for the observed reduction in RhoA activity upon cell adhesion (Arthur et al., 2000; Arthur and Burridge, 2001) . Growth factor signaling leading to the inactivation of Rho via p190RhoGAP phosphorylation has also been reported and is mediated via a complex of Src, mDia and DIP, where Src phosphorylates DIP . Hence it is plausible that the phosphorylation of DIP by Src may play a critical role in the integrin-mediated suppression of Rho. It is interesting to note that FAK can bind the SH2 domain of Grb2 after Src-mediated phosphorylation of tyrosine 925. DIP contains a proline-rich region that binds Grb2, presumably through one of its SH3 domains (Satoh and Tominaga, 2001) . It is tempting to speculate that the mechanism behind enhanced Src-dependent phosphorylation of tyrosine 925 and motility of Caco-2 colorectal cancer cells may be due to increased DIP activity via a complex of Grb2, FAK and DIP (Sanders and Basson, 2004) . It should be noted that DIP also links Src signaling to Rac activation, via recruitment of the Vav2 exchange factor . Furthermore, expression of a dominant-negative Vav2 mutant blocked fibronectindependent formation of lamellipodia (Marignani and Carpenter, 2001) . Therefore, DIP may be a central component in the coordination of integrin-or growth factor-mediated Rac and Rho signaling. While Vav1 is clearly activated downstream of integrin signaling in hematopoietic cells, integrin-dependent cell adhesion does not result in activation of Vav proteins in other cell types (Moores et al., 2000) . Thus the role of DIP, and the mechanism of Rac regulation downstream of integrins, remains to be established.
A second proposed mechanism of regulating Rho activity is via paxillin. A recent interesting publication demonstrated co-immunoprecipitation of p120RasGAP with paxillin mediated through the two SH2 domains of p120RasGAP (Tsubouchi et al., 2002) . The docking sites on paxillin are the phosphorylated tyrosine residues at 31 and 118. Overexpression of a paxillin mutant that cannot be phosphorylated at these sites enhanced Rho activity following cell adhesion and impaired lamellipodia formation (Tsubouchi et al., 2002) . Tyrosinephosphorylated paxillin competes with p190RhoGAP for binding to p120RasGAP (Tsubouchi et al., 2002) . Hence, cell adhesion-dependent tyrosine phosphorylation of paxillin may titrate p120RasGAP from p190RhoGAP. This results in an elevation in the activity of p190RhoGAP, and consequently a reduction in the level of Rho activity (Tsubouchi et al., 2002) . In summary, the activation of Rho seems to be balanced by a competition for interaction with an inhibitor of p190RhoGAP, p120RasGAP, between paxillin and p190RhoGAP.
Role of cortactin
Cortactin is another protein involved in cell motility, and is phosphorylated by Src on tyrosine residues 421 and 466 (Head et al., 2003) . Cortactin is recruited to sites of cortical actin polymerization in a Rac-and p21-activated kinase (PAK)-dependent manner (Weed and ). In addition, cortactin has been shown to interact with WIP (WASP-interacting protein) (Kinley et al., 2003) . The cortactin-WIP interaction has been shown to increase the efficiency of Arp2/3 complex activation. Hence, cortactin is believed to contribute to filopodia or lamellipodia formation (Kinley et al., 2003) .
Interplay between Src kinases and cortactin seems to be important particularly in cells of high metastatic potential (Li et al., 2001; Huang et al., 2003) . Hence, activation of the cortactin-WIP-Arp2/3 pathway is likely an additional mechanism by which activated Src augments cell motility in a tumor.
Role of PIPKIc661
PIPKIg661, a splice variant of PIPKg with a unique carboxy-terminal tail, associates via the unique region with talin and localizes to focal adhesions (Di Paolo et al., 2002; Ling et al., 2002) . PIPKIg661 is phosphorylated at tyrosine 644 within the unique tail by SFKs, although in vivo FAK functions to promote tyrosine phosphorylation of PIPKIg661 by Src (Di Paolo et al., 2002; Ling et al., 2002 Ling et al., , 2003 . This phosphorylation event is important for the efficient association of PIPKIg661 with talin and for localization to focal adhesions (Ling et al., 2003) . Phosphatidyl inositol 4,5-bisphosphate (PIP 2 ), which is the product generated by phosphorylation of PIP by PIP kinases, regulates the interactions between a number of cytoskeletal proteins, including the association of talin with the cytoplasmic domains of the integrin b subunits and the binding of vinculin to talin (Nayal et al., 2004) . Recruitment of PIPKIg661 to talin may promote local production of PIP 2 and consequently the assembly of protein complexes. Talin binding to integrin is a major mechanism of inside-out signaling, whereby cytoplasmic events alter integrin function promoting interactions with extracellular ligands (Tadokoro et al., 2003) . Talin also plays a critical role in linking integrins to the actin cytoskeleton . Modulation of cytoskeletal function via PIPKIg661 is an attractive mechanism by which SFKs may regulate cell function. Activation of talin may promote activation of integrins or tethering of integrins to the cytoskeleton, both of which might result in increased adhesion. However, the role of SFKs in inside-out signaling remains to be fully elucidated, and SFK function in regulating tethering of integrins to the cytoskeleton is complex, as described above. This is also an intriguing mechanism for regulating the formation of focal adhesions. However, srcÀ/À and SYF fibroblasts assemble vinculin containing focal adhesions normally, suggesting that SFKs do not regulate focal adhesion assembly (Kaplan et al., 1994; Klinghoffer et al., 1999; Volberg et al., 2001) . PIPKIg661 could also play a role in promoting spreading and motility by regulating the conformation of vinculin and recruitment of the Arp2/3 complex (DeMali et al., 2002) . While PIPKIg661 is emerging as an important regulator of cytoskeletal function, defining the precise role of SFKs requires further analysis.
Potential antagonist of integrin/Src signaling pathways
Besides the major negative regulator of Src activity, Csk, it is noteworthy that Src signaling pathways can also be regulated by the input of other signaling molecules. A number of these molecules target downstream proteins in the integrin signaling pathway and are briefly discussed below.
c-Abl
The Abl nonreceptor tyrosine kinase was originally identified as the cellular homolog of the v-Abl oncogene product found in Abelson murine leukemia virus (Goff et al., 1980; reviewed in Pendergast, 2002) . Given that Abl is an oncogene with some similarity to Src, one would perhaps expect that the effects of activated c-Abl on cell motility would be similar to Src. However, expression of activated c-Abl in embryonic fibroblasts and COS-7 cells was found to inhibit migration, whereas a kinase-inactive c-Abl mutant enhances migration (Kain and Klemke, 2001) . The inhibition of cell migration by c-Abl was proposed to occur by phosphorylation of tyrosine 221 of Crk, which uncouples the interaction with p130
CAS (Kain and Klemke, 2001 ). Thus, c-Abl activation could potentially antagonize SFK-mediated responses to cell adhesion by blocking transmission of signals beyond p130 CAS .
Cbl
Cbl proteins are a family of ubiquitin ligases that function in the downregulation of signaling cascades involving receptor and nonreceptor tyrosine kinases (reviewed in Sanjay et al., 2001a) . Activation of integrin avb3 in osteoclasts induced the assembly of a Cbl/ autophosphorylated Src/activated Pyk2 tripartite complex. This leads to inhibition of Src kinase activity and integrin-mediated adhesion and cell motility (Sanjay et al., 2001b) . Perhaps the loss of Cbl-mediated regulation of integrin signaling explains, at least in part, the osteopetrotic phenotype in srcÀ/À cells (Soriano et al., 1991) . Expression of Cbl has also been shown to suppress anchorage-independent growth in v-Src-transformed cells .
PTP-PEST
SFK signaling can also be antagonized by the actions of PTPs. For example, PTP-PEST has been shown to bind p130 CAS and paxillin and induce their dephosphorylation in vivo (Garton et al., 1996; Shen et al., 1998) . In addition, PTP-PEST expression has been shown to inhibit motility of fibroblasts (Garton and Tonks, 1999; Sastry et al., 2002) . The specific event leading to PTP-PEST-mediated inhibition of cell motility was an apparent reduction in p130 CAS phosphorylation and p130 CAS -Crk association following cell adhesion (Garton and Tonks, 1999) . Furthermore, PTP-PEST overexpression has been shown to suppress adhesiondependent activation of Rac1 with concomitant motility defects (Sastry et al., 2002) . It seems likely that endogenous PTP-PEST may contribute to cell motility by inhibition of Rac-mediated pathways via dephosphorylation of paxillin or p130 CAS . Paradoxically, ptppestÀ/À cells also show motility defects (Garton et al., 1996; Angers-Loustau et al., 1999; Sastry et al., 2002) . Thus either enhanced or impaired PTP-PEST activity inhibits cell motility. These results can be explained if tyrosine phosphorylation of key substrates must be transient in order to promote motility or if tyrosine phosphorylation of key substrates must be spatially restricted.
Crosstalk between integrins and other signaling pathways
Crosstalk is the term given to the transfer of signaling potential from one biochemical pathway to another, for instance from an integrin-mediated pathway to one initiated from growth factor receptors. Crosstalk is an important mechanism for multicellular organisms to coordinate or synergistically regulate normal cellular processes such as cell proliferation, migration and angiogenesis (Eliceiri, 2001; Schwartz and Ginsberg, 2002) . However, hyperactivation of signaling components caused by genetic mutation or overexpression could lead to deregulation of these processes and improper cell responses such as tumor formation and metastasis. Evidence has suggested that crosstalk may occur at many levels. Firstly, crosstalk may occur at the receptor level. Integrins have been shown to co-immunoprecipitate with EGF and insulin receptors (Yu et al., 2000) . Secondly, receptor docking molecules such as IRS-1 have been shown to co-immunoprecipitate with both integrins and the insulin family of growth factor receptors (Vuori and Ruoslahti, 1994; Schneller et al., 1997; Lebrun et al., 1998) . Tyrosine phosphorylation of IRS-1 and the insulin receptor was shown to be enhanced upon cell adhesion (El Annabi et al., 2001) . Re-expression of integrin avb3 in cells lacking this integrin was shown to restore adhesion-dependent deficiencies in DNA synthesis upon insulin treatment (Vuori and Ruoslahti, 1994) . Thirdly, FAK, acting as a bridge, rather than a kinase may regulate crosstalk between EGFR and ephrin receptors during integrin signaling (Miao et al., 2000; Sieg et al., 2000) . That SFKs are components of many signaling pathways (discussed in this issue) suggests that they are likely proponents of crosstalk between integrin-mediated pathways. Here we briefly discuss two possibilities of cellular crosstalk, involving integrins with growth factor receptors or the cadherin family of cell-cell adhesion molecules.
Integrins and growth factor receptors
One example of crosstalk is the evidence of a role for integrins in EGFR-mediated mitogenic response (Moro et al., 1998) . It was shown that Src kinase activity was required for integrin-mediated transactivation of the EGFR during mitogenesis (Moro et al., 2002) . Interestingly, the residues involved in EGFR transphosphorylation by integrin were noted to differ from those phosphorylated in response to EGF (Moro et al., 2002) . A potential crosstalk mechanism was suggested whereby a complex of EGFR, Src, integrin and p130 CAS was formed to facilitate EGFR activation (Moro et al., 2002) . Src kinase activity was found to be critical for the adhesion-dependent formation of this complex (Moro et al., 2002) .
In endothelial cells, there is strong evidence of crosstalk between integrin avb5 and VEGFR signaling, which contributes to angiogenesis (Friedlander et al., 1995; Eliceiri et al., 1999) . VEGF treatment of endothelial cells induced formation of a FAK/avb5 complex in an Src-dependent manner (Eliceiri et al., 2002) . It appeared that the tyrosine 861 residue of FAK was critical for the Src-dependent formation of the FAK/ avb5 complex. It is interesting to note that in endothelial cells, FAK binds to b1 and b3 constitutively but the interaction with b5 is Src-inducible (Eliceiri et al., 2002) . In support of these results in vitro, mice deficient in Src or integrin b5 exhibit deficiencies in vascular permeability in vivo in response to VEGF (Eliceiri et al., 2002) .
Integrins and cadherins
Cadherins are a family of calcium-dependent homotypic cell-cell adhesion molecules (reviewed in Wheelock and Johnson, 2003) . The role of SFKs in the regulation of cell-cell adhesion has been described in another paper in this issue. Two studies have implicated a role for Src in the regulation of cell-cell contacts via integrin signaling (Genda et al., 2000; Avizienyte et al., 2002) . In response to cell-ECM adhesion, Genda et al. (2000) observed an activation of Src with concomitant reduction in cell-cell adhesion in hepatocellular carcinoma cells. These effects were found to be inhibited by b1-and b5-specific neutralizing antibodies (Genda et al., 2000) . In a later study, elevated Src activity in colon cancer cells was shown to induce disorganization of normal cell-cell contact formation . Under these conditions, E-cadherin remained cytoplasmic even at physiological levels of calcium. In addition, vinculin was redistributed from adherens junctions (sites of cadherinmediated contacts) to cell-ECM complexes . The redistribution of vinculin or E-cadherin in activated Src-expressing cells could be inhibited by disrupting integrin-mediated signaling using specific antibodies or by coexpression of a FAK variant lacking the Src target tyrosine phosphorylation sites.
Influence of activated Src/v-Src integrin signaling in cancer V-Src-transformed cells exhibit several different phenotypic alterations, such as changes in cell shape and acquisition of anchorage and growth factor independence. The differences in sequence and structure between Src and v-Src have been described elsewhere (Martin, 2001) , and in this issue. We will now discuss the influence of v-Src on functions normally controlled by integrin and Src signaling.
V-Src affects cell motility in vitro/invasion in vivo V-Src-transformed cells exhibit weakened cell adhesion and increased focal adhesion turnover, which are characteristics of increased cell motility. At the integrin level, v-Src has been shown to influence integrin function by direct phosphorylation of tyrosine residues or via indirect phosphorylation of R-Ras (Sakai et al., 2001; Zou et al., 2002) . V-Src-mediated phosphorylation of b1A integrin was found to occur on tyrosines 783 and 795 (Sakai et al., 2001) . V-Src expression induced a reduction in adhesion of cells expressing wild-type b1A integrin, but could less effectively impair adhesion of cells expressing a b1A variant with both of these tyrosine residues mutated to phenylalanine (Datta et al., 2001) . In the second, indirect mechanism of regulating adhesion, activated Src or v-Src interacts with and phosphorylates a member of the Ras family of GTPases (Zou et al., 2002) . Tyrosine phosphorylation by v-Src was found to negate normal R-Ras function in the enhancement of integrin-mediated adhesion Zou et al., 2002) . Taken together, these two studies provide evidence of two mechanisms by which vSrc expression can alter signaling to promote a less adhesive phenotype.
It has been known for many years that v-Src-mediated transformation of avian fibroblasts in vitro leads to FAK degradation and focal adhesion turnover (Fincham et al., 1995; Fincham and Frame, 1998) . The involvement of calpain 2 and ERK kinase in the regulation of FAK turnover has been described above (Carragher et al., 2003) . The conclusion to be drawn here is that the enhanced motility of v-Src-transformed cells may in part be attributed to altered regulation of focal adhesion turnover.
V-Src-transformed cells exhibit an enhanced propensity for invasion in vivo relative to untransformed cells (Behrens et al., 1993) . Evidence has suggested that FAK may play a key role in the invasive capacity of v-Srctransformed cells (Hauck et al., 2002a, b; Zou et al., 2002; Hsia et al., 2003) . V-Src has been shown to form complexes with FAK at integrin b1-containing cell protrusions termed invadopodia (Hauck et al., 2002a) . The importance of FAK for v-Src-induced cell invasion was demonstrated by expression of a dominant-negative mutant of FAK. This mutant inhibited invasion in vitro and metastasis in vivo, but did not alter cell migration, proliferation or growth of the cells into a tumor in nude mice (Hauck et al., 2002b) . Further support for the role of FAK in v-Src-mediated cell invasion came from the observation that v-Src-expressing FAK null fibroblasts are motile but noninvasive (Hsia et al., 2003) . Furthermore, a FAK-p130 CAS -Crk-Dock180-JNK-MMP-2 pathway was implicated in v-Src-mediated invasion (Hauck et al., 2002b; Hsia et al., 2003) . Several other studies have provided evidence for the increased production of MMPs in v-Src-transformed cells (Kadono et al., 1998; Aguirre-Ghiso et al., 1999; Cha et al., 2000; Kurata et al., 2000) .
Integrin/Src signaling pathway as future treatment target Src is an obvious therapeutic target in tumors exhibiting elevated Src activity. This review has detailed the role of Src in normal integrin-regulated biochemical pathways and biological processes. Therefore, Src may also be an effective therapeutic target in some cancers where altered integrin profiles contribute to the disease or in controlling other integrin-regulated processes like angiogenesis. Further, many components of the signaling pathways downstream of Src have been elucidated. Concise knowledge of these biochemical pathways have led already (reviewed by Jin and Varner, 2004) and will in future lead to the design of more effective therapeutic strategies for the treatment of malignancy.
